NASDAQ:SIENSientra Stock Price, Forecast & News

Sientra's stock was trading at $2.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SIEN shares have increased by 62.3% and is now trading at $3.96.
View which stocks have been most impacted by COVID-19.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Sientra.

Sientra is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Sientra.

Sientra Inc (NASDAQ:SIEN) announced its quarterly earnings data on Monday, August, 10th. The medical instruments supplier reported ($0.68) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.45) by $0.23. Sientra had a negative return on equity of 101.94% and a negative net margin of 134.87%.
View Sientra's earnings history.

6 brokers have issued 12-month price objectives for Sientra's stock. Their forecasts range from $5.00 to $9.00. On average, they expect Sientra's share price to reach $6.80 in the next twelve months. This suggests a possible upside of 71.7% from the stock's current price.
View analysts' price targets for Sientra.

Headlines about SIEN stock have trended neutral recently, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sientra earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term.
View the latest news about Sientra.

Sientra saw a decrease in short interest in June. As of June 15th, there was short interest totaling 4,410,000 shares, a decrease of 18.5% from the May 31st total of 5,410,000 shares. Based on an average trading volume of 1,870,000 shares, the short-interest ratio is currently 2.4 days. Approximately 10.3% of the company's stock are sold short.
View Sientra's Short Interest.

Some companies that are related to Sientra include Inogen (INGN), Establishment Labs (ESTA), Invacare (IVC), RTI Surgical (RTIX), Lakeland Industries (LAKE), Histogenics (HSGX), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Ocugen (OCGN), Allied Healthcare Products (AHPI), Rewalk Robotics (RWLK), Precision Therapeutics (POAI), Bionik Laboratories (BNKL), NanoVibronix (NAOV) and Avitar (AVTI).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), Matinas BioPharma (MTNB), Rigel Pharmaceuticals (RIGL), Micron Technology (MU), Sorrento Therapeutics (SRNE), Novavax (NVAX), Miragen Therapeutics (MGEN), Oasis Petroleum (OAS) and ADMA Biologics (ADMA).

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Sientra's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Deerfield Management Company L.P. Series C (8.27%), UBS Group AG (4.82%), Mutual of America Capital Management LLC (2.62%), Goldman Sachs Group Inc. (2.49%), Assenagon Asset Management S.A. (1.00%) and HighTower Advisors LLC (0.71%). Company insiders that own Sientra stock include Jeffrey M Nugent, Keith J Sullivan, Paul Sean Little and Timothy Haines.
View institutional ownership trends for Sientra.

SIEN stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Deerfield Management Company L.P. Series C, UBS Group AG, HighTower Advisors LLC, SG Americas Securities LLC, and Algert Global LLC.
View insider buying and selling activity for Sientra.

SIEN stock was bought by a variety of institutional investors in the last quarter, including Mutual of America Capital Management LLC, Assenagon Asset Management S.A., Baird Financial Group Inc., California Public Employees Retirement System, State of Wisconsin Investment Board, Bank of New York Mellon Corp, Rockefeller Capital Management L.P., and Wedbush Securities Inc.. Company insiders that have bought Sientra stock in the last two years include Keith J Sullivan, and Paul Sean Little.
View insider buying and selling activity for Sientra.

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SIEN stock can currently be purchased for approximately $3.96.

Sientra has a market capitalization of $199.24 million and generates $83.70 million in revenue each year. The medical instruments supplier earns $-106,820,000.00 in net income (profit) each year or ($2.29) on an earnings per share basis. Sientra employs 339 workers across the globe.

The official website for Sientra is www.sientra.com.

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]